Somatosensation Device Trial

Amputation Clinical Trial

Official title:

Testing of the Somatosensation Device (SD) for Device Effectiveness While Enhancing Feedback in Lower Extremities

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06168396
• Other study ID #: STU00219855
• Status: Recruiting
• Phase: N/A
• Start date: March 1, 2024
• Est. completion date: December 2025

Study information

• Verified date: April 2024
• Source: Shirley Ryan AbilityLab
• Contact: Arun Jayaraman, PhD
• Phone: 312-238-6875
• Email: ajayaraman[@]sralab.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research is being done to test a new device, called the Somatosensation Device, with people who have either a below knee amputation, or neuropathy (i.e. decreased sensation) in their legs. When people have lost sensation in their feet, it may make walking and balance more difficult. The Somatosensation Device is designed to substitute the loss of feeling in a foot by pressing on nerves on the surface of the leg. It presses on the nerves by using a pneumatic balloon to put pressure on your skin. If people receive this extra sensation feedback, it may help improve their walking and balance.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20
• Est. completion date: December 2025
• Est. primary completion date: December 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

• Have a below-knee amputation (either unilateral or bilateral) or neuropathy in their lower limbs.
• Ability to wear the somatosensation device on their lower limbs
• Ability to wear test equipment and heart rate monitors.
• Ability to follow simple directions.

Exclusion Criteria:

• History of severe back pain in the last 3 months.
• History of severe knee pain in the last 3 months.
• Unable to walk for 3 minutes with or without an assistive device
• Poor skin integrity (i.e open wounds, skin breakdown) that could be made worse by wearing the somatosensation device.

Related Conditions & MeSH terms

• Amputation
• Neuropathy

Intervention

Device:
• Somatosensation Device
The somatosensation device will be worn on the lower limb (either the residual limb for an amputee, or limb with decreased sensation for a participant with diabetic neuropathy) while performing outcome measures.

Other:
• Baseline
Participants will perform outcome measures without wearing the somatosensation device.

Locations

Country	Name	City	State
United States	Shirley Ryan AbilityLab	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
Shirley Ryan AbilityLab

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional Gait Assessment (FGA)	The Functional Gait Assessment is a test to assess an individual's postural stability and ability to perform multiple motor tasks while walking. Tests include walking at different speeds, walking with head turns, turns, stepping over obstacles, walking tandem, walking with eyes closed, walking backwards, and stair navigation. Scores are on a 0-30 scale, with higher scores showing better balance and mobility.	Baseline, during the intervention
Secondary	10 Meter Walk Test	The 10MWT assesses walking speed in meters per second. In the 10MWT, subjects are directed to walk at their self-selected and maximum safe speed with the effects of acceleration and deceleration minimized (by adding 2 meters at the beginning and at the end of the course to isolate the subject's steady state speed). Any assistive device and orthotic should be kept consistent and documented. Participants will complete three trials at their self-selected speed and three trials at their fast but still safe speed. This will be performed over the GAITRite electronic walkway, to measure temporal-spatial gait parameters.	Baseline, during the intervention
Secondary	Mini-BESTest	A multi-task balance assessment that identifies postural control problems across a wide variety of situations.	Baseline, during the intervention
Secondary	Activities Specific Balance Confidence Scale (ABC)	A self-reported questionnaire that measures a participant's confidence in their balance in performing various activities without falling or becoming unsteady. Scores are on a 0-100% confidence scale, with higher scores equaling greater confidence.	Baseline, during the intervention
Secondary	Vestibular Disorders Activities of Daily Living Scale (VADL)	A self-reported questionnaire that evaluates the effects of vertigo and balance disorders on independence routine activities of daily living. Scores range from 1-8, with lower scores indicating greater independence with activities.	Baseline, during the intervention